Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer

Ovarian cancer can be cured in up to 90% of cases if diagnosed early. CA125, the most studied ovarian cancer biomarker, exhibits poor sensitivity for detecting early disease stages and low specificity to malignancy. RECAF, the alpha-fetoprotein receptor, is a wide-spectrum oncofetal antigen with cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Tcherkassova, Janneta, Abramovich, Carolina, Moro, Rafael, Chen, Chen, Schmit, Ralph, Gerber, Angela, Moro, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131516/
https://www.ncbi.nlm.nih.gov/pubmed/21625941
http://dx.doi.org/10.1007/s13277-011-0186-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131516/
https://www.ncbi.nlm.nih.gov/pubmed/21625941
http://dx.doi.org/10.1007/s13277-011-0186-1

Ejemplares similares